News and Updates

Dr. Campbell Joins Experts in New Initiative to Support Older Cancer Survivors – OHSU News

By Owen Chen on November 4, 2024

This past October, Oregon Health & Science University (OHSU) hosted a meeting in Portland, bringing together experts to develop the first-ever exercise guidelines tailored specifically for older cancer survivors. Led by Dr. Kerri Winters-Stone, a team of experts—including our very own Dr. Kristin Campbell—came together to launch the ACES initiative (Advancing Capacity to Integrate Exercise […]

Read More | No Comments

New publication: Can aerobic exercise help prevent brain fog caused by chemotherapy?

By Owen Chen on October 29, 2024

Our latest study “Aerobic exercise and CogniTIVe functioning in women with breAsT cancEr (ACTIVATE): A randomized controlled trial” has just been published in Cancer! Our trial aimed to determine if aerobic exercise can help prevent chemotherapy-induced cognitive impairment, more commonly known as brain fog or chemo-brain. In the trial, we found that women with breast […]

Read More | No Comments

Catalyst 360 Podcast

By ssawer on August 2, 2024

Check out Dr. Kristin Campbell on Catalyst 360 Podcast! She is discussing all things exercise oncology, listen to the episode here: https://www.buzzsprout.com/204059/15207284

Read More | No Comments

Sarah Weller: Featured Alumni!

By thejlam on June 10, 2024

Former CEPL member, Sarah Weller, has been selected as the June 2024 Alumni of the Month, in the Rehabilitation Sciences e-newsletter! Sarah graduated with a Master’s of Science in 2019. She contributed to and lead various exercise oncology research initiatives within the CEPL, such as leading a systematic review, mobilizing a passion project on bone […]

Read More | No Comments

The Canadian Cancer Society – 4 research projects improving cancer care in rural and remote areas

By thejlam on April 25, 2024

  An article from the Canadian Cancer Society featuring 4 research projects, of which we are one! Click here to read the article.  

Read More | No Comments